BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 17, Issue 10
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review
©The Author(s) 2025.
World J Hepatol. Oct 27, 2025; 17(10): 108810
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.108810
Figure 3
Full Size Figure Download Figure
Figure 3 Schematic representation of therapeutic strategies for liver fibrosis. Nanoparticles, microbubbles paired with ultrasound, or a mix of the two can be used to deliver drug-based and gene-based therapies. Microbubble oscillation transiently disrupts endothelial and extracellular matrix barriers, enhancing nanoparticle uptake. These delivery systems aim to improve tissue penetration and therapeutic efficacy.
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.